Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 10/9/2025

Management of Rhabdomyolysis and AKI Secondary to Bee Sting

Immediate First Aid and Anaphylaxis Management

  • The American Heart Association recommends removing any retained stingers immediately by plucking or scraping, as venom delivery continues for up to 30-60 seconds while embedded in skin 3
  • The American Heart Association suggests activating emergency medical services immediately if any signs of anaphylaxis develop, such as difficulty breathing, tongue/throat swelling, lightheadedness, vomiting, or disseminated hives 3
  • The American Heart Association recommends administering epinephrine autoinjector if available and anaphylaxis is present, as this is the primary treatment regardless of triggering agent 3, 4
  • Washing the sting area with soap and water is recommended 3

Fluid Resuscitation Strategy

  • The American College of Surgeons recommends administering >6L of intravenous fluids to prevent AKI and need for renal replacement therapy in patients with severe rhabdomyolysis 1, 2
  • The American College of Surgeons suggests initiating volume resuscitation as early as possible, as delayed initiation is associated with higher rates of AKI development 1, 2
  • For moderate rhabdomyolysis, administering 3-6L per day of intravenous fluids is recommended 1, 2

Monitoring and Detection Protocol

  • Repeated laboratory assessments should be performed, combining plasma myoglobin levels, plasma creatine phosphokinase (CPK) measurements, and potassium (kalemia) measurements 1, 2
  • Urinary monitoring should include placing a bladder catheter to monitor hourly urine output 1
  • Monitoring frequency should be every 30 minutes to 1 hour during the first 24 hours 2

Nephrotoxin Avoidance

  • The National Kidney Foundation recommends immediately discontinuing all potentially nephrotoxic medications, including NSAIDs, statins, and other medications with nephrotoxic potential 5, 6, 7, 8
  • Combining three or more nephrotoxins more than doubles AKI risk, with 25% of patients receiving three or more nephrotoxins developing AKI 6, 7, 8

Supportive Care

  • Antihistamines may be used for local reactions, though systemic manifestations take priority 3